HomeCompareSUSRF vs PEP

SUSRF vs PEP: Dividend Comparison 2026

SUSRF yields 70.42% · PEP yields 3.63%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SUSRF wins by $930.3K in total portfolio value
10 years
SUSRF
SUSRF
● Live price
70.42%
Share price
$2.84
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.07M
Annual income
$282,657.96
Full SUSRF calculator →
PEP
PepsiCo Inc.
● Live price
3.63%
Share price
$156.82
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$141.9K
Annual income
$61,875.67
Full PEP calculator →

Portfolio growth — SUSRF vs PEP

📍 SUSRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSUSRFPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SUSRF + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SUSRF pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SUSRF
Annual income on $10K today (after 15% tax)
$5,985.92/yr
After 10yr DRIP, annual income (after tax)
$240,259.27/yr
PEP
Annual income on $10K today (after 15% tax)
$308.41/yr
After 10yr DRIP, annual income (after tax)
$52,594.32/yr
At 15% tax rate, SUSRF beats the other by $187,664.95/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SUSRF + PEP for your $10,000?

SUSRF: 50%PEP: 50%
100% PEP50/50100% SUSRF
Portfolio after 10yr
$607.1K
Annual income
$172,266.82/yr
Blended yield
28.38%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

SUSRF
No analyst data
Altman Z
2.7
Piotroski
6/9
PEP
Analyst Ratings
1
Strong
15
Buy
27
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+10.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SUSRF buys
0
PEP buys
0
No recent congressional trades found for SUSRF or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSUSRFPEP
Forward yield70.42%3.63%
Annual dividend / share$2.00$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$1.07M$141.9K
Annual income after 10y$282,657.96$61,875.67
Total dividends collected$914.3K$123.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: SUSRF vs PEP ($10,000, DRIP)

YearSUSRF PortfolioSUSRF Income/yrPEP PortfolioPEP Income/yrGap
1← crossover$17,742$7,042.25$10,849$509.42+$6.9KSUSRF
2$30,661$11,677.14$11,969$750.47+$18.7KSUSRF
3$51,667$18,859.73$13,500$1,124.14+$38.2KSUSRF
4$84,985$29,701.39$15,680$1,721.66+$69.3KSUSRF
5$136,593$45,658.47$18,929$2,715.34+$117.7KSUSRF
6$214,738$68,583.71$24,023$4,450.80+$190.7KSUSRF
7$330,537$100,766.97$32,510$7,669.92+$298.0KSUSRF
8$498,633$144,958.95$47,709$14,093.60+$450.9KSUSRF
9$737,910$204,372.63$77,415$28,083.48+$660.5KSUSRF
10$1,072,222$282,657.96$141,922$61,875.67+$930.3KSUSRF

SUSRF vs PEP: Complete Analysis 2026

SUSRFStock

Surgical Science Sweden AB (publ) develops and markets virtual reality (VR) simulators for evidence-based laparoscopic and endoscopic training. It offers LapSim training system comprising LapSim ST develops to train surgical technologists and surgical assistants; and LapSim essence, a portable and ready-to-use VR simulator. The company also provides EndoSim system, an endoscopy simulator that delivers medical simulation training; TeamSim, a dynamic platform for inter-professional education development taking surgery simulation into the real world teamwork; Simball Box, which offers feedback on velocity with tutorial task videos showing a preferred approach; simbionix simulators; and robotic surgery simulators. Surgical Science AB was founded in 1999 and is headquartered in Gothenburg, Sweden.

Full SUSRF Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this SUSRF vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SUSRF vs SCHDSUSRF vs JEPISUSRF vs OSUSRF vs KOSUSRF vs MAINSUSRF vs MOSUSRF vs PMSUSRF vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.